140 related articles for article (PubMed ID: 9480156)
21. White blood cell-reduced platelet concentrates prepared by filtration using the Sepacell PL 5 II/10 II filter.
Müller N; Knop D
Beitr Infusionsther Transfusionsmed; 1994; 32():58-60. PubMed ID: 9422102
[TBL] [Abstract][Full Text] [Related]
22. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
23. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
24. [Thrombocyte concentrates prepared from the buffy coat. A modified method].
Gasová Z; Turek P
Cas Lek Cesk; 1996 Jan; 135(3):89-91. PubMed ID: 8625376
[TBL] [Abstract][Full Text] [Related]
25. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
26. Fully automated processing of buffy-coat-derived pooled platelet concentrates.
Janetzko K; Klüter H; van Waeg G; Eichler H
Transfusion; 2004 Jul; 44(7):1052-8. PubMed ID: 15225247
[TBL] [Abstract][Full Text] [Related]
27. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
Moog R
J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
[TBL] [Abstract][Full Text] [Related]
28. National French observatory of the quality of blood components for transfusion.
Chabanel A; Masse M; Begue S;
Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
[TBL] [Abstract][Full Text] [Related]
29. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
Mohr H; Bayer A; Gravemann U; Müller TH
Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811
[TBL] [Abstract][Full Text] [Related]
30. Leukoreduction of platelet concentrates using a 'polishing' filter.
van der Meer PF; Pietersz RN; Reesink HW
Vox Sang; 2000; 79(1):27-33. PubMed ID: 10971211
[TBL] [Abstract][Full Text] [Related]
31. [Lymphocyte interactions in platelet concentrates from buffy coats. Determination of proliferating cells using Ki-67 antibodies].
Müller-Steinhardt M; Klüter H; Kirchner H
Beitr Infusionsther Transfusionsmed; 1994; 32():66-8. PubMed ID: 9480160
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
33. White cell subsets in apheresis and filtered platelet concentrates.
Sowemimo-Coker SO; Kim A; Tribble E; Brandwein HJ; Wenz B
Transfusion; 1998 Jul; 38(7):650-7. PubMed ID: 9683103
[TBL] [Abstract][Full Text] [Related]
34. [Blood transfusion preparations with a low leukocyte count. I. Preparation of thrombocyte concentrates from buffy coats].
Gasová Z; Turek P
Cas Lek Cesk; 1992 Dec; 131(24-25):754-5. PubMed ID: 1288879
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: a retrospective analysis of count increment, corrected count increment and transfusion interval.
Cid J; Ramiro L; Escoda L; Llorente A
Vox Sang; 2009 Jan; 96(1):29-33. PubMed ID: 19121195
[TBL] [Abstract][Full Text] [Related]
36. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
[TBL] [Abstract][Full Text] [Related]
37. [Quality control in producing thrombocytapheresis preparations with minimal leukocyte contamination].
Riggert J; Humpe A; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1997; 34():89-94. PubMed ID: 9417356
[TBL] [Abstract][Full Text] [Related]
38. Preparation of small volume, leuko and erythrocyte very poor platelet concentrates.
Valbonesi M; Angelini G; Malfanti L; Lercari G; Fella M; Calderisi S; Anselmo A; Balistreri M
Int J Artif Organs; 1986 May; 9(3):189-92. PubMed ID: 3733246
[TBL] [Abstract][Full Text] [Related]
39. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
Seghatchian J
Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
[TBL] [Abstract][Full Text] [Related]
40. Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC.
Pietersz RN; van der Meer PF; Steneker I; Hinloopen B; Dekker WJ; van Zanten AP; Reesink HW
Vox Sang; 1999; 76(4):231-6. PubMed ID: 10394143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
